🔎 Trials Near Me

Home › Stomach Cancer › California › Santa Rosa

Stomach Cancer clinical trials in Santa Rosa, CA

5 studies for Stomach Cancer are looking for participants at sites in and around Santa Rosa (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Distance-Based Exercise to Preserve Function and Prevent Disability

Recruiting
  • Kaiser Permanente-Santa Rosa, Santa Rosa
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Providence Medical Foundation - Santa Rosa, Santa Rosa
  • Providence Santa Rosa Memorial Hospital, Santa Rosa
  • Saint Helena Hospital, St. Helena · 14 mi away
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

RecruitingPhase 2
  • Research Site, Santa Rosa
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06219941

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

RecruitingPhase 2
  • Research Site, Santa Rosa
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT05489211

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

RecruitingPhase 1/2
  • Providence Medical Foundation, Santa Rosa
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT04198766

About Stomach Cancer

Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.

More about Stomach Cancer on MedlinePlus

Stomach Cancer trials in other cities

Other studies in Santa Rosa

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.